These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 30528843)

  • 1. Universal Screening for Hepatitis C: An Important Step in Virus Elimination.
    Chhatwal J; Sussman NL
    Clin Gastroenterol Hepatol; 2019 Apr; 17(5):835-837. PubMed ID: 30528843
    [No Abstract]   [Full Text] [Related]  

  • 2. Universal Screening for Hepatitis C Virus Infection: A Step Toward Elimination.
    Graham CS; Trooskin S
    JAMA; 2020 Mar; 323(10):936-937. PubMed ID: 32119041
    [No Abstract]   [Full Text] [Related]  

  • 3. Economic evaluation of the hepatitis C elimination strategy in Greece in the era of affordable direct-acting antivirals.
    Gountas I; Sypsa V; Papatheodoridis G; Souliotis K; Athanasakis K; Razavi H; Hatzakis A
    World J Gastroenterol; 2019 Mar; 25(11):1327-1340. PubMed ID: 30918426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elimination of hepatitis C virus in Germany: modelling the cost-effectiveness of HCV screening strategies.
    Krauth C; Rossol S; Ortsäter G; Kautz A; Krüger K; Herder B; Stahmeyer JT
    BMC Infect Dis; 2019 Dec; 19(1):1019. PubMed ID: 31791253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C Virus Infection in the Pregnant Woman: Is It Time for Universal Screening?
    Sheffield JS; Argani CH
    Obstet Gynecol; 2020 Apr; 135(4):770-772. PubMed ID: 32168232
    [No Abstract]   [Full Text] [Related]  

  • 6. Universal screening for hepatitis C virus infection should be linked to universal treatment access.
    Dore GJ; Matthews GV
    Nat Rev Gastroenterol Hepatol; 2020 Jun; 17(6):321-322. PubMed ID: 32350442
    [No Abstract]   [Full Text] [Related]  

  • 7. The economics of hepatitis C virus.
    Shah BB; Wong JB
    Clin Liver Dis; 2006 Nov; 10(4):717-34. PubMed ID: 17164114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Universal Screening of Pregnant Women for Hepatitis C: The Time Is Now.
    Jhaveri R; Broder T; Bhattacharya D; Peters MG; Kim AY; Jonas MM
    Clin Infect Dis; 2018 Oct; 67(10):1493-1497. PubMed ID: 30215670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. European paediatric hepatitis C virus network. Antenatal hepatitis C virus screening and management of infected women and their children: policies in Europe.
    Pembrey L; Newell ML; Tovo PA
    Eur J Pediatr; 1999 Oct; 158(10):842-6. PubMed ID: 10486090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiologic predictors of hepatitis C virus infection in pregnant women.
    Leikin EL; Reinus JF; Schmell E; Tejani N
    Obstet Gynecol; 1994 Oct; 84(4):529-34. PubMed ID: 7522312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of screening blood donors for hepatitis C and non-A, non-B, non-C hepatitis. The EATHIS Eco Research Group. European Acute Transfusion Hepatitis Interferon Study.
    Colin C; Vergnon P; Jullien AM; Excoffier S; Matillon Y; Trepo C
    Eur J Clin Microbiol Infect Dis; 1997 Mar; 16(3):220-7. PubMed ID: 9131325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transplanting Hepatitis C Virus-Infected or Uninfected Kidneys Into Hepatitis C Virus-Infected Recipients.
    Kiberd B; Doucette K; Vinson A; Tennankore K
    Ann Intern Med; 2018 Dec; 169(12):897-898. PubMed ID: 30557434
    [No Abstract]   [Full Text] [Related]  

  • 13. Opportunistic HCV screening in the general population: New insights for a graduated birth cohort approach.
    Conti F; Beltrami M; Pagani G; Giacomelli A
    Liver Int; 2023 Mar; 43(3):737-738. PubMed ID: 36689312
    [No Abstract]   [Full Text] [Related]  

  • 14. Cost effectiveness of adding nucleic acid testing to hepatitis B, hepatitis C, and human immunodeficiency virus screening of blood donations in Zimbabwe.
    Mafirakureva N; Mapako T; Khoza S; Emmanuel JC; Marowa L; Mvere D; Postma MJ; van Hulst M
    Transfusion; 2016 Dec; 56(12):3101-3111. PubMed ID: 27696441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and screening costs of hepatitis C virus among Ugandan blood donors.
    Hladik W; Kataaha P; Mermin J; Purdy M; Otekat G; Lackritz E; Alter MJ; Downing R
    Trop Med Int Health; 2006 Jun; 11(6):951-4. PubMed ID: 16772018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for hepatitis C virus infection in adults.
    Rich JD; Taylor LE; Allen SA
    Ann Intern Med; 2004 Oct; 141(7):575-6; author reply 576. PubMed ID: 15466778
    [No Abstract]   [Full Text] [Related]  

  • 17. Transplanting Hepatitis C Virus-Infected or Uninfected Kidneys Into Hepatitis C Virus-Infected Recipients.
    Eckman MH; Woodle ES; Thakar CV; Paterno F; Sherman KE
    Ann Intern Med; 2018 Dec; 169(12):898-899. PubMed ID: 30557435
    [No Abstract]   [Full Text] [Related]  

  • 18. Who to screen for hepatitis C? A cost-effectiveness study in Belgium of comprehensive hepatitis C screening in four target groups.
    Opstaele L; Bielen R; Bourgeois S; Moreno C; Nevens F; Robaeys G; Robaeys G; Van Vlierberghe H
    Acta Gastroenterol Belg; 2019; 82(3):379-387. PubMed ID: 31566325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C: is there a case for universal screening in pregnancy?
    Martyn F; Phelan O; O'Connell M
    Ir Med J; 2011 May; 104(5):144-6. PubMed ID: 21736090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is antenatal screening for hepatitis C virus cost-effective? A decade's experience at a London centre.
    Selvapatt N; Ward T; Bailey H; Bennett H; Thorne C; See LM; Tudor-Williams G; Thursz M; McEwan P; Brown A
    J Hepatol; 2015 Oct; 63(4):797-804. PubMed ID: 26024832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.